933708-92-0 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid is utilized as a lead compound in pharmaceutical research and drug development due to its demonstrated biological activities. Its potential as an anticancer, antiviral, and antibacterial agent makes it an important target for the discovery and development of new therapeutics.
Used in Medicinal Chemistry:
In the realm of medicinal chemistry, [1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid is employed as a key structural motif for the design and synthesis of novel compounds with enhanced pharmacological properties. Its unique molecular framework allows for the exploration of structure-activity relationships and the optimization of drug candidates for various therapeutic applications.
Used in Anticancer Applications:
[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid is used as an anticancer agent for its potential to target and inhibit the growth of cancer cells. Its derivatives have shown significant pharmacological activities, making it a valuable component in the development of anticancer drugs.
Used in Antiviral and Antibacterial Applications:
[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid is also used in the development of antiviral and antibacterial agents, leveraging its inherent biological activities to combat viral and bacterial infections, thereby contributing to the advancement of treatments for various infectious diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 933708-92-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,7,0 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 933708-92:
(8*9)+(7*3)+(6*3)+(5*7)+(4*0)+(3*8)+(2*9)+(1*2)=190
190 % 10 = 0
So 933708-92-0 is a valid CAS Registry Number.
933708-92-0Relevant articles and documents
COMPOUNDS AND USES THEREOF
-
, (2020/10/20)
The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.
COMPOUNDS AND USES THEREOF
-
, (2019/10/15)
The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
Keeping it small, polar, and non-flat: diversely functionalized building blocks containing the privileged 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]- and [1,5-a]pyridine cores
Mishchuk, Alexander,Shtil, Natalia,Poberezhnyk, Mykola,Nazarenko, Konstiantyn,Savchenko, Timur,Tolmachev, Andrey,Krasavin, Mikhail
, p. 1056 - 1059 (2016/02/16)
Six sets of functionalized building blocks based on 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine as well as 5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a]pyridine cores have been prepared. These compounds are non-flat, bicyclic heterocycles that are likely to find utility as privileged motifs for lead-like compound design. One set of building blocks, (5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-6-ylmethyl)amines, proved useful as a scaffold for developing compounds that stimulate glucagon-like peptide-1 (GLP-1) secretion and are novel anti-diabetes drug leads.
